Characteristic | Participated N = 112 (%) | Refused to participate N = 40 (%) | Excluded N = 70 (%) |
---|---|---|---|
Mean age at screening (SD) | 73.7 year (6.0) | 74.4 year (5.8) | 76.2 year (6.6) |
Sex (%) | Â | Â | Â |
Female | 78 (69.6) | 21 (52.5) | 39 (55.7) |
Male | 34 (30.4) | 19 (47.5) | 31 (44.3) |
Language of the patient (%) | Â | Â | Â |
French | 41 (36.6) | 8 (20.0) | 12 (17.1) |
English | 71 (63.4) | 32 (80.0) | 22 (31.4) |
Neither | 0 | 0 | 21 (30.0) |
No information | 0 | 0 | 15 (21.4) |
Marital status (%) | Â | Â | Â |
Married/living common-law | 62 (55.4) | 31 (77.5) | 45 (64.3) |
Widowed | 25 (22.3) | 7 (17.5) | 12 (17.1) |
Separated/divorced | 19 (17.0) | 0 | 2 (2.9) |
Single | 6 (5.4) | 0 | 6 (8.6) |
No Information | 0 | 2 (5.0) | 5 (7.1) |
Type of cancer (%) | Â | Â | Â |
Lung | 27 (24.1) | 17 (42.5) | 28 (40.0) |
Breast | 44 (39.3) | 11 (27.5) | 21 (30.0) |
Colorectal | 20 (17.9) | 7 (17.5) | 11 (15.7) |
Lymphoma & myeloma | 21 (18.8) | 5 (12.5) | 10 (14.3) |
Treatment proposed (%) | Â | Â | Â |
Watchful waiting | 2 (1.8) | 1 (2.5) | 11 (15.7) |
Surgery | 54 (48.2) | 19 (47.5) | 28 (40.0) |
Chemotherapy | 42 (37.5) | 15 (37.5) | 14 (20.0) |
Radiation therapy | 10 (8.9) | 4 (10.0) | 9 (12.9) |
Hormonal therapy | 4 (3.6) | 1 (2.5) | 4 (5.7) |
Other | 0 | 0 | 4 (5.7) |
Cancer diagnosis (%) | Â | Â | Â |
First diagnosis | 100 (89.3) | 34 (85.0) | 62 (88.6) |
Recurrence | 2 (1.8) | 4 (10.0) | 6 (8.6) |
New diagnosis, not first cancer diagnosis | 10 (8.9) | 2 (5.0) | 2 (2.9) |